Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Inventory (2022 - 2025)

Arcutis Biotherapeutics (ARQT) has 4 years of Inventory data on record, last reported at $22.4 million in Q3 2025.

  • For Q3 2025, Inventory rose 59.96% year-over-year to $22.4 million; the TTM value through Sep 2025 reached $22.4 million, up 59.96%, while the annual FY2024 figure was $14.5 million, 10.6% up from the prior year.
  • Inventory reached $22.4 million in Q3 2025 per ARQT's latest filing, up from $16.6 million in the prior quarter.
  • Across five years, Inventory topped out at $22.4 million in Q3 2025 and bottomed at $4.3 million in Q3 2022.
  • Average Inventory over 4 years is $13.3 million, with a median of $13.9 million recorded in 2024.
  • Peak YoY movement for Inventory: skyrocketed 74.79% in 2023, then rose 10.6% in 2024.
  • A 4-year view of Inventory shows it stood at $7.5 million in 2022, then surged by 74.79% to $13.1 million in 2023, then rose by 10.6% to $14.5 million in 2024, then soared by 54.34% to $22.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $22.4 million in Q3 2025, $16.6 million in Q1 2025, and $14.5 million in Q4 2024.